We are live on ! Find out more
HP

Hikari Power Portfolio holdings

AUM $855M
1-Year Est. Return 14.24%
This Fund
S&P 500
This Quarter Est. Return
+8.23%
1 Year Est. Return
+14.24%
3 Year Est. Return
+53.45%
5 Year Est. Return
+75.51%
10 Year Est. Return
+220.8%
AUM
$1.01B
AUM Growth
+$63.5M
Cap. Flow
-$20.3M
Cap. Flow %
-2%
Top 10 Hldgs %
69.21%
Holding
71
New
4
Increased
10
Reduced
7
Closed
1

Top Buys

Rank Stock Value
1
ABBV icon
AbbVie
ABBV
+$2.16M
2
VHT icon
Vanguard Health Care ETF
VHT
+$550K
3
VNT icon
Vontier
VNT
+$542K
4
VZ icon
Verizon
VZ
+$539K
5
MRK icon
Merck
MRK
+$514K

Top Sells

Rank Stock Value
1
WFC icon
Wells Fargo
WFC
+$18.3M
2
NTR icon
Nutrien
NTR
+$6.87M
3
CSCO icon
Cisco
CSCO
+$473K
4
BUD icon
AB InBev
BUD
+$299K
5
MO icon
Altria Group
MO
+$260K

Sector Composition

Rank Sector Weight
1 Financials 46.39%
2 Healthcare 18.74%
3 Industrials 7.26%
4 Materials 5.97%
5 Technology 4.41%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PH icon
51
Parker-Hannifin
PH
$134B
$691K 0.07%
2,250
– –
PRU icon
52
Prudential Financial
PRU
$42.2B
$651K 0.06%
6,350
– –
MET icon
53
MetLife
MET
$61.5B
$633K 0.06%
10,580
– –
VEEV icon
54
Veeva Systems
VEEV
$38.4B
$622K 0.06%
2,000
– –
VHT icon
55
Vanguard Health Care ETF
VHT
$19B
$568K 0.06%
+2,300
New +$550K
VZ icon
56
Verizon
VZ
$196B
$527K 0.05%
+9,400
New +$539K
ASHR icon
57
Xtrackers Harvest CSI 300 China A-Shares ETF
ASHR
$1.58B
$474K 0.05%
+11,700
New +$466K
ECL icon
58
Ecolab
ECL
$79.8B
$433K 0.04%
2,100
– –
NVCR icon
59
NovoCure
NVCR
$2.06B
$377K 0.04%
1,700
– –
BABA icon
60
Alibaba
BABA
$306B
$247K 0.02%
+1,090
New +$242K
ALDX icon
61
Aldeyra Therapeutics
ALDX
$91.1M
$227K 0.02%
20,020
– –
AKTX
62
Akari Therapeutics
AKTX
$13.5M
$155K 0.02%
112
– –
ALPN
63
DELISTED
Alpine Immune Sciences Inc
ALPN
$94K 0.01%
10,445
– –
BDSI
64
DELISTED
BioDelivery Sciences International, Inc.
BDSI
$90K 0.01%
25,000
– –
AMRN
65
Amarin Corp
AMRN
$296M
$66K 0.01%
750
– –
CRVS icon
66
Corvus Pharmaceuticals
CRVS
$1.24B
$53K 0.01%
19,959
– –
ADMA icon
67
ADMA Biologics
ADMA
$2.22B
$48K ﹤0.01%
30,075
– –
TGTX icon
68
TG Therapeutics
TGTX
$7.64B
– –
-5,000
Closed -$241K
1 2
3

Similar funds

QIM
Quest Investment Management Lake Oswego, Oregon $857M AUM 21.67% 1-Year Est. Return
NOCM
Night Owl Capital Management Greenwich, Connecticut $858M AUM 31.41% 1-Year Est. Return
OAM
Ophir Asset Management Sydney, Australia $859M AUM 59.08% 1-Year Est. Return
EPIMS
Evelyn Partners Investment Management Services London $850M AUM 20.89% 1-Year Est. Return
BCM
Benchstone Capital Management New York $860M AUM 32.46% 1-Year Est. Return
PCM
Parsifal Capital Management Greenwich, Connecticut $849M AUM 28.52% 1-Year Est. Return
BOTOTLSJU
Board of Trustees of The Leland Stanford Junior University Redwood City, California $849M AUM 55.45% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return

Hikari Power's Q2 2021 Portfolio in Review

As of Q2 2021, Hikari Power held 71 positions worth $1.01B, up 6.7% from $950M the previous quarter. Its ten largest holdings account for 69% of the portfolio.

Hikari Power's Q2 2021 filing shows 4 new, 10 increased, 7 reduced and 1 closed positions. Its largest new stake was Vanguard Health Care ETF: 2,300 shares worth $568K. The largest sale was Wells Fargo, an estimated $18.3M.

By sector, the portfolio is most concentrated in Financials at 46% of assets, down from 47% a quarter earlier, followed by Healthcare and Industrials.

  • Hikari Power's largest Q2 2021 buy was Vanguard Health Care ETF: 2,300 shares worth $568K.
  • Hikari Power added most to AbbVie in Q2 2021, an estimated $2.16M increase.
  • Hikari Power's biggest Q2 2021 reduction was Wells Fargo, cutting an estimated $18.3M.
  • Hikari Power fully exited TG Therapeutics in Q2 2021, selling an estimated $241K.
  • Hikari Power's ten largest holdings make up 69% of its $1.01B portfolio in Q2 2021.
  • Hikari Power opened 4 new positions and closed 1 in Q2 2021.
  • Hikari Power's portfolio value rose 6.7% quarter-over-quarter to $1.01B.

Based on Hikari Power's 13F filing for Q2 2021, filed 7 Jul 2021.